Clinical Trial Update: Treatment of Orthostatic Hypotension [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update for treatment of orthostatic hypotension; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autonomic Nervous System Diseases
• Dopamine Beta-hydroxylase Deficiency
• Orthostatic Hypotension
• Orthostatic Intolerance

Snippet

Sponsor: Vanderbilt University | Conditions: Autonomic Nervous System Diseases, Orthostatic Hypotension | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2022-03-02